Bean J, Brennan C, Shih J-Y, Riely G, Viale A, Wang L, Chitale D, Motoi N, Szoke J, Broderick S, Balak M, Chang W-C, Yu C-J, Gazdar A, Pass H, Rusch V, Gerald W, Huang S-F, Yang P-C, Miller V, Ladanyi M, Yang C-H and Pao W (2007) MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
Intranasal delivery to the central nervous system: mechanisms and experimental considerations. Journal of Pharmaceutical Sciences , 2010
Tuy nhin, s an ton khi s dng lu di hoc qun tr ton thn vn cn c xc minh thm
Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases
Cycling with breaks of 2-4 weeks between protocols may help maintain response